Document Detail


KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.
MedLine Citation:
PMID:  22230399     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
This study investigates whether KMUP-1 protects soluble guanylate cyclase (sGC) and inhibits vascular endothelial growth factor (VEGF) expression in lung epithelial cells in hypoxia, therapeutically targeting epithelial proinflammation. H441 cells were used as a representative epithelial cell line to examine the role of sGC and VEGF in hypoxia and the anti-proinflammatory activity of KMUP-1 in normoxia. Human H441 cells were grown in hypoxia for 24-72 h. KMUP-1 (1, 10, 100 microM) arrested cells at the G0/G1 phase of the cell cycle, reduced cell survival and migration, increased p21/p27, restored eNOS, increased soluble guanylate cyclase (sGC) and PKG and inhibited Rho kinase II (ROCK-II). KMUP-1 (0.001-0.1 microM) concentration dependently increased eNOS in normoxia and did not inhibit phosphodiesterase-5A (PDE-5A) in hypoxic cells. Hypoxia-induced factor-1alpha (HIF-1alpha) and VEGF were suppressed by KMUP-1 but not by L-NAME (100 microM). The PKG inhibitor Rp-8-CPT-cGMPS (10 microM) blunted the inhibition of ROCK-II by KMUP-1. KMUP-1 inhibited thromboxane A2-mimetic agonist U46619-induced PDE-5A, TNF-alpha (100 ng/ml)-induced iNOS, and ROCK-II and associated phospho-p38 MAPK, suggesting multiple anti-proinflammatory activities. In addition, increased p21/p27 by KMUP-1 at higher concentrations might contribute to an increased Bax/Bcl-2 and active caspase-3/procaspase-3 ratio, concomitantly causing apoptosis. KMUP-1 inhibited ROCK-II/VEGF in hypoxia, indicating its anti-neoplastic and anti-inflammatory properties. KMUP-1 inhibited TNF-alpha-induced iNOS and U46619-induced PDE-5A and phospho-p38 MAPK in normoxia, confirming its anti-proinflammatory action. KMUP-1 could be used as an anti-proinflammatory to reduce epithelial inflammation.
Authors:
B N Wu; H Y Chen; C P Liu; L Y Hsu; I J Chen
Related Documents :
8382679 - Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells.
6167289 - Cyclic nucleotide metabolism in rat colonic epithelial cells with different proliferati...
2454919 - Inhibition of gonadotropin-responsive adenylate cyclase in ma-10 leydig tumor cells by ...
11048649 - Dexamethasone enhances phospholipase d activity in m-1 cells.
19204889 - Primary differences in lipolysis between human omental and subcutaneous adipose tissue ...
6138039 - Induced maturation of the human promyelocytic leukemia cell line, hl-60, by 2-beta-d-ri...
19920079 - Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis.
24135219 - Protective effect of orexin-a on 6-hydroxydopamine-induced neurotoxicity in sh-sy5y hum...
620089 - Defective iron uptake and globin synthesis by erythroid cells in the anemia of the belg...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of immunopathology and pharmacology     Volume:  24     ISSN:  0394-6320     ISO Abbreviation:  Int J Immunopathol Pharmacol     Publication Date:    2011 Oct-Dec
Date Detail:
Created Date:  2012-01-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8911335     Medline TA:  Int J Immunopathol Pharmacol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  925-40     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
Next Document:  Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier ar...